Jnci-journal Of The National Cancer Institute

Jnci-journal Of The National Cancer Institute

美国国家癌症研究所Jnci杂志

  • 1区 中科院分区
  • Q1 JCR分区

期刊简介

《Jnci-journal Of The National Cancer Institute》是由Oxford University Press出版社于1940年创办的英文国际期刊(ISSN: 0027-8874,E-ISSN: 1460-2105),该期刊长期致力于肿瘤学领域的创新研究,主要研究方向为ONCOLOGY。作为SCIE收录期刊(JCR分区 Q1,中科院 1区),本刊采用OA未开放获取模式(OA占比0.2637...%),以发表肿瘤学领域等方向的原创性研究为核心(研究类文章占比94.54%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在183篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Jnci-journal Of The National Cancer Institute审稿周期约为 。该刊近年未被列入国际预警名单,年发文量约183篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 183 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
1区
ONCOLOGY 肿瘤学
1区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
1区
ONCOLOGY 肿瘤学
1区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 28 / 322

91.5%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 23 / 322

93.01%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:17 SJR:4.986 SNIP:2.556
学科类别 分区 排名 百分位
大类:Medicine 小类:Oncology Q1 28 / 404

93%

大类:Medicine 小类:Cancer Research Q1 21 / 230

91%

期刊发文

  • DNA methylation profile in CpG-depleted regions uncovers a high-risk subtype of early-stage colorectal cance
  • Design and reporting of phase III oncology trials with prospective biomarker validatio
  • Ultra-processed food consumption and risk of colorectal cancer precursors: results from 3 prospective cohort
  • Risk prediction models for endometrial cancer: development and validation in an international consortiu
  • Recommendations for Epstein-Barr virus-based screening for nasopharyngeal cancer in high- and intermediate-risk region
  • Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinom
  • Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients

    Author: Lambertini M1, Campbell C2, Bines J, Korde LA3, Izquierdo M4, Fumagalli D5, Del Mastro L6, Ignatiadis M1, Pritchard K7, Wolff AC8, Jackisch C9, Lang I10, Untch M11, Smith I12, Boyle F13, Xu B14, Barrios CH15, Baselga J16,17, Moreno-Aspitia A18, Piccart M1, Gelber RD19, de Azambuja E1

    Journal: J Natl Cancer Inst. 2019 Jan 1;111(1):86-94. doi: 10.1093/jnci/djy094

  • Novel Common Genetic Susceptibility Loci for Colorectal Cancer

    Author: Schmit SL1,2, Edlund CK2, Schumacher FR3, Gong J4, Harrison TA4, Huyghe JR4, Qu C2,4, Melas M2, Van Den Berg DJ2, Wang H5, Tring S2,6,7, Plummer SJ8, Albanes D9, Alonso MH10,11,12, Amos CI13, Anton K13, Aragaki AK4, Arndt V14, Barry EL15, Berndt SI9, Bezieau S4, Bien S16, Bloomer A1, Boehm J17, Boutron-Ruault MC18,19, Brenner H14,20,21, Brezina S22, Buchanan DD23,24,25, Butterbach K14, Caan BJ26, Campbell PT27, Carlson CS4, Castelao JE28, Chan AT29,30, Chang-Claude J31,32,33, Chanock SJ9, Cheng I34, Cheng YW35, Chin LS36, Church JM37, Church T38, Coetzee GA39, Cotterchio M40, Cruz Correa M41, Curtis KR4, Duggan D42, Easton DF43, English D44, Feskens EJM45, Fischer R46, FitzGerald LM44,47, Fortini BK48, Fritsche LG49,50, Fuchs CS51,52, Gago-Dominguez M53,54, Gala M29, Gallinger SJ55, Gauderman WJ2, Giles GG23,44, Giovannucci EL32,56, Gogarten SM57, Gonzalez-Villalpando C58, Gonzalez-Villalpando EM59, Grady WM60, Greenson JK61, Gsur A62, Gunter M30, Haiman CA2, Hampe J63, Harlid S64, Harju JF46, Hayes RB65, Hofer P62, Hoffmeister M14, Hopper JL66, Huang SC2, Huerta JM67, Hudson TJ68,69, Hunter DJ70, Idos GE2, Iwasaki M71, Jackson RD72, Jacobs EJ27, Jee SH73, Jenkins MA23, Jia WH74, Jiao S4, Joshi AD30,70, Kolonel LN75, Kono S22, Kooperberg C4, Krogh V76, Kuehn T77, Küry S78, LaCroix A4, Laurie CA57, Lejbkowicz F1, Lemire M69, Lenz HJ2,79, Levine D57, Li CI80, Li L81, Lieb W82, Lin Y4, Lindor NM83, Liu YR84, Loupakis F35, Lu Y85, Luh F86, Ma J87, Mancao C88, Manion FJ46, Markowitz SD89, Martin V90, Matsuda K91, Matsuo K92,93, McDonnell KJ2, McNeil CE2, Milne R23,44, Molina AJ11,94, Mukherjee B46, Murphy N95, Newcomb PA4, Offit K96, Omichessan H18,19, Palli D97, Cotoré JPP98, Pérez-Mayoral J99, Pharoah PD100, Potter JD4, Qu C2,4, Raskin L85,91, Rennert G86,101,102, Rennert HS86,101, Riggs BM1, Schafmayer C103, Schoen RE104, Sellers TA1, Seminara D105, Severi G18,106, Shi W107, Shibata D108, Shu XO85,91, Siegel EM1, Slattery ML109, Southey M24, Stadler ZK96,110, Stern MC2, Stintzing S111, Taverna D112, Thibodeau SN113, Thomas DC2, Trichopoulou A114, Tsugane S2,6,7, Ulrich CM17, van Duijnhoven FJB45, van Guelpan B, Vijai J96, Virtamo J115, Weinstein SJ9, White E4, Win AK23, Wolk A116, Woods M117, Wu AH2, Wu K118, Xiang YB119, Yen Y35,120, Zanke BW121,122, Zeng YX74, Zhang B123, Zubair N4, Kweon SS124,125, Figueiredo JC126,127, Zheng W85,91, Marchand LL5, Lindblom A128, Moreno V10,11,12, Peters U129, Casey G8, Hsu L4, Conti DV2, Gruber SB2,79

    Journal: J Natl Cancer Inst. 2019 Feb 1;111(2):146-157. doi: 10.1093/jnci/djy099